Clinical Trials Directory

Trials / Completed

CompletedNCT03094247

Feeding Malnourished Children Different Types of Fatty Acids to Promote Neurocognitive Development

Improved Polyunsaturated Ready-to-use Therapeutic Food for Improved Neurocognitive Outcomes in Severe Acute Malnutrition

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,897 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
6 Months – 59 Months
Healthy volunteers
Not accepted

Summary

An appropriate balance of omega-6 and omega-3 fatty acids is important for support of neurocognitive development in healthy infants and toddlers. In young children recovering from severe acute malnutrition (SAM), excess omega-6 intake depletes omega-3 fatty acid status. This research will evaluate how novel ready-to-use therapeutic foods (RUTF) with balanced fatty acids improve the metabolic and neurocognitive effects in young children in Malawi recovering from SAM, yielding new knowledge that also has implications for development of well-nourished children.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillinAll patients with severe acute malnutrition will receive a course of amoxicillin.
DIETARY_SUPPLEMENTHO-RUTFHO-RUTF: Milk, perilla oil, palm oil, white sugar, high oleic peanuts
DIETARY_SUPPLEMENTD-HO-RUTFD-HO-RUTF: DHA, milk, perilla oil, palm oil, white sugar, high oleic peanuts
DIETARY_SUPPLEMENTS-RUTFS-RUTF: Milk, canola oil, palm oil, white sugar, standard peanuts

Timeline

Start date
2017-10-02
Primary completion
2021-03-23
Completion
2021-03-23
First posted
2017-03-29
Last updated
2022-07-19

Locations

1 site across 1 country: Malawi

Source: ClinicalTrials.gov record NCT03094247. Inclusion in this directory is not an endorsement.